Home › Companies › SUMMIT THERAPEUTICS INC. › 2023-2024

SUMMIT THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and SUMMIT THERAPEUTICS INC.’s Form 8-K, filed 2024-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 12Reported items
  • 108Asset managers
  • 1,478Fund votes
  • 2024-06-14Main meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore SUMMIT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by SUMMIT THERAPEUTICS INC.

These tallies are SUMMIT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SUMMIT THERAPEUTICS INC. — official shareholder meeting results, meeting held 2024-06-14
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Robert W. Duggan 620,632,521---- 362,13318,922,547 Majority: yes
Elect Director: Mahkam Zanganeh 620,696,167---- 298,48718,922,547 Majority: yes
Elect Director: Manmeet S. Soni 620,032,830---- 961,82418,922,547 Majority: yes
Elect Director: Kenneth A. Clark 612,562,945---- 8,431,70918,922,547 Majority: yes
Elect Director: Robert Booth 620,631,600---- 363,05418,922,547 Majority: yes
Elect Director: Alessandra Cesano 613,253,170---- 7,741,48418,922,547 Majority: yes
Elect Director: Yu Xia 620,368,580---- 626,07418,922,547 Majority: yes
Elect Director: Mostafa Ronaghi 619,032,689---- 1,961,96518,922,547 Majority: yes
Elect Director: Ratification of the appointment of PricewaterhouseCoopers LLP, United States 639,287,77639,750589,675 ---- Majority: yes
Elect Director: Approval, on a non-binding advisory basis, of the compensation of the named executive officers. 604,242,48215,872,371879,801 --18,922,547 Majority: yes

Source: SUMMIT THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-17 — read the filing on EDGAR.

How asset managers voted at the SUMMIT THERAPEUTICS INC. 2023-2024 meetings

Each item below shows how the 108 asset managers that disclosed a SUMMIT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SUMMIT THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, by a non-binding advisory vote, of the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 604,242,482AGAINST: 15,872,371

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Approval, on a non-binding advisory basis, of the compensation of the named executive officers.”): 604,242,482 for, 15,872,371 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).

The 105 asset managers below cast 5% of the shares they voted on this item FOR (1,014,172 for, 21,027,171 against).

AGAINST 95%
FOR: 1,014,172 (4.6%)AGAINST: 21,027,171 (95.3%)ABSTAIN: 19,142 (0.1%)
Largest asset managers voting on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity05,019,187 00Against
BlackRock62,9993,610,545 00Against
State Street2,1943,282,531 00Against
GEODE CAPITAL MANAGEMENT, LLC02,003,519 00Against
Charles Schwab01,600,808 00Against
Vanguard01,559,232 00Against
Northern Trust604,4181,565 00For
MELLON INVESTMENTS Corp0428,286 00Against
First Trust0356,386 00Against
Wellington0266,881 00Against
Federated Hermes0229,668 00Against
UBS0168,172 00Against
SECTORAL ASSET MANAGEMENT INC165,0000 00For
BANK OF AMERICA NA0146,281 00Against
MARSHALL WACE, LLP0143,148 00Against
Equitable0136,448 00Against
John Hancock0131,110 00Against
ProShares0125,996 00Against
Direxion Shares ETF Trust0113,719 00Against
Rafferty Asset Management, LLC0113,719 00Against
Lincoln Financial098,100 00Against
AllianceBernstein094,410 00Against
HoyleCohen, LLC83,0470 00For
PRINCIPAL GLOBAL INVESTORS079,752 00Against
Voya078,932 00Against

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

2. ELECTION OF DIRECTORS: Alessandra Cesano

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 613,253,170WITHHELD: 7,741,484

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 613,253,170 for, 7,741,484 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 87% for, 1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (5,212,307 for, 0 against).

FOR 54.7%ABSTAIN 45.3%
FOR: 5,212,307 (54.7%)ABSTAIN: 4,310,589 (45.3%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Alessandra Cesano” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,085,4590 68,4510For
BlackRock00 1,563,0230Abstain
Vanguard00 1,423,3060Abstain
State Street2,5630 1,012,9670Abstain
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable94,4100 42,0380For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial00 98,1000Abstain
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya00 39,4660Abstain
Pacific Life00 37,1620Abstain
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust00 22,1790Abstain
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

3. ELECTION OF DIRECTORS: Kenneth A. Clark

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 612,562,945WITHHELD: 8,431,709

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth A. Clark”): 612,562,945 for, 8,431,709 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 87% for, 1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (4,589,540 for, 0 against).

FOR 48.2%ABSTAIN 51.8%
FOR: 4,589,540 (48.2%)ABSTAIN: 4,933,356 (51.8%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Kenneth A. Clark” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity00 3,153,9100Abstain
BlackRock00 1,563,0230Abstain
Vanguard1,423,3060 00For
State Street1,015,3600 1700For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable94,4100 42,0380For
ProShares125,9960 00For
Federated Hermes00 114,8340Abstain
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life00 37,1620Abstain
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust00 22,1790Abstain
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

4. ELECTION OF DIRECTORS: Mahkam Zanganeh

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,696,167WITHHELD: 298,487

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mahkam Zanganeh”): 620,696,167 for, 298,487 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,522,856 for, 0 against).

FOR 99.9%
FOR: 9,522,856 (100.0%)ABSTAIN: 40 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Mahkam Zanganeh” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 400For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

5. ELECTION OF DIRECTORS: Manmeet S. Soni

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 620,032,830WITHHELD: 961,824

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Manmeet S. Soni”): 620,032,830 for, 961,824 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.2% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,375,244 for, 0 against).

FOR 98%
FOR: 9,375,244 (98.4%)ABSTAIN: 147,652 (1.6%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Manmeet S. Soni” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 400For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 114,8340Abstain
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI00 30,8000Abstain
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

6. ELECTION OF DIRECTORS: Mostafa Ronaghi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 619,032,689WITHHELD: 1,961,965

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mostafa Ronaghi”): 619,032,689 for, 1,961,965 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.3% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (8,382,790 for, 0 against).

FOR 88%12%
FOR: 8,382,790 (88.0%)ABSTAIN: 1,140,106 (12.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Mostafa Ronaghi” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity2,013,8040 1,140,1060For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

7. ELECTION OF DIRECTORS: Robert Booth

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,631,600WITHHELD: 363,054

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Booth”): 620,631,600 for, 363,054 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,522,896 for, 0 against).

FOR 100%
FOR: 9,522,896 (100.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert Booth” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

8. ELECTION OF DIRECTORS: Robert W. Duggan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,632,521WITHHELD: 362,133

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert W. Duggan”): 620,632,521 for, 362,133 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,522,856 for, 0 against).

FOR 99.9%
FOR: 9,522,856 (100.0%)ABSTAIN: 40 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert W. Duggan” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 400For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

9. ELECTION OF DIRECTORS: Ujwala Mahatme

DIRECTOR ELECTIONS

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 87%13%

The 41 asset managers below cast 100% of the shares they voted on this item FOR (8,267,786 for, 0 against).

FOR: 8,267,786 (86.8%)ABSTAIN: 1,255,110 (13.2%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Ujwala Mahatme” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity2,013,8040 1,140,1060For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,3600 1700For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 114,8340Abstain
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

10. ELECTION OF DIRECTORS: Yu Xia

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 620,368,580WITHHELD: 626,074

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yu Xia”): 620,368,580 for, 626,074 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 88% for, 0.1% withheld (88% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,408,022 for, 0 against).

FOR 99%
FOR: 9,408,022 (98.8%)ABSTAIN: 114,874 (1.2%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Yu Xia” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 400For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 114,8340Abstain
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

11. Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-06-14.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 639,287,776AGAINST: 39,750

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ratification of the appointment of PricewaterhouseCoopers LLP, United States”): 639,287,776 for, 39,750 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 701,974,596 outstanding shares: 91% for, 0.1% against (91% of the company cast a for/against vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (9,522,896 for, 0 against).

FOR 100%
FOR: 9,522,896 (100.0%)
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

12. To approve an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to increase the number of shares of the Company's common stock issuable under the Plan by 70,000,000 shares.

COMPENSATION

Meeting held 2023-10-12; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

5% fund support · no official result

AGAINST 95%

The 33 asset managers below cast 5% of the shares they voted on this item FOR (164,237 for, 3,287,537 against).

FOR: 164,237 (4.8%)AGAINST: 3,287,537 (95.2%)
Largest asset managers voting on “To approve an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to increase the number of sh” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock01,014,497 00Against
Vanguard0716,539 00Against
Fidelity0518,291 00Against
ALPS ETF Trust0420,576 00Against
Equitable0165,880 00Against
Lincoln Financial98,1000 00For
ETF Series Solutions065,808 00Against
Northern Trust51,4790 00For
ETFis Series Trust I050,714 00Against
Voya046,304 00Against
AIG/SunAmerica045,041 00Against
Brighthouse040,272 00Against
Pacific Life037,635 00Against
John Hancock034,154 00Against
Bridge Builder Trust020,304 00Against
Federated Hermes017,877 00Against
Charles Schwab015,739 00Against
ProShares015,567 00Against
Nationwide014,279 00Against
Principal012,084 00Against
Invesco011,452 00Against
State Street10,2580 00For
Calvert09,569 00Against
PENN SERIES FUNDS INC4,4000 00For
Morgan Stanley03,907 00Against

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Largest SUMMIT THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of SUMMIT THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 701,974,596 shares outstanding at the time of that meeting.

Top SUMMIT THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 0.72%
2BlackRock 0.52%
3State Street 0.47%
4GEODE CAPITAL MANAGEMENT, LLC 0.29%
5Charles Schwab 0.23%
6Vanguard 0.22%
7Northern Trust 0.09%
8MELLON INVESTMENTS Corp 0.06%
9First Trust 0.05%
10Wellington 0.04%

Reported SUMMIT THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

SUMMIT THERAPEUTICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Robert W. Duggan 78.12% DEF14A
Mahkam Zanganeh 5.04% DEF14A
Vanguard Group 1.62% 13F
FMR (Fidelity) 1.27% 13F
State Street 1.16% 13F
BlackRock 1.05% 13F
Geode Capital 0.45% 13F
Morgan Stanley 0.27% 13F
Northern Trust 0.15% 13F
Charles Schwab 0.14% 13F

Percentages above are of 701,974,596 shares outstanding, as reported by SUMMIT THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SUMMIT THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At SUMMIT THERAPEUTICS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held 2023-10-12 and 2024-06-14), 108 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,478 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2024-06-14 — Approval, by a non-binding advisory vote, of the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SUMMIT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-17.

SUMMIT THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.